Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
3.
Resuscitation ; 85(5): 649-56, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24555950

RESUMEN

INTRODUCTION: After cardiac arrest due to acute coronary syndromes (ACS) therapeutic hypothermia (HT) is the standard care to reduce neurologic damage. Additionally, the concomitant medical treatment with aspirin and a P2Y12 receptor inhibitor like clopidogrel (Cl), prasugrel (Pr) or ticagrelor (Ti) is mandatory. The platelet inhibitory effect of these drugs under hypothermia remains unclear. METHODS: 164 patients with ACS were prospectively enrolled in this study. 84 patients were treated with HT, 80 patients were under normothermia (NT). All patients were treated with aspirin and one of the P2Y12 receptor inhibitors Cl, Pr or Ti. 24h after the initial loading dose the platelet reactivity index (PRI/VASP-index) was determined to achieve the platelet inhibitory effect. RESULTS: In the HT-group the PRI/VASP-index was significantly higher compared to the NT-group (54.86%±25.1 vs. 28.98%±22.8; p<0.001). In patients under HT receiving Cl, the platelet inhibition was most markedly reduced (HT vs. NT: 66.39%±19.1 vs. 33.36%±22.1; p<0.001) compared to Pr (HT vs. NT: 37.6%±25.0 vs. 27.04%±25.5; p=0.143) and Ti (HT vs. NT: 41.5%±21.0 vs. 17.83%±14.5; p=0.009). The rate of non-responder defined as PRI/VASP-index>50% was increased in HT compared to NT (60.7% vs. 22.5%; p<0.001) with the highest rates in the group receiving Cl (CL: 82% vs. 26%, p<0.001; Pr: 32% vs. 23%; n.s.; Ti: 30% vs. 8%, n.s.). CONCLUSION: The platelet inhibitory effect in patients treated with HT after cardiac arrest is significantly reduced. This effect was most marked with the use of Cl. The new P2Y12-inhibitors Pr and Ti improved platelet inhibition in HT, but could not completely prevent non-responsiveness.


Asunto(s)
Adenosina/análogos & derivados , Paro Cardíaco/terapia , Hipotermia Inducida , Piperazinas/uso terapéutico , Antagonistas del Receptor Purinérgico P2Y/uso terapéutico , Tiofenos/uso terapéutico , Adenosina/uso terapéutico , Clopidogrel , Femenino , Citometría de Flujo , Humanos , Masculino , Persona de Mediana Edad , Inhibidores de Agregación Plaquetaria/uso terapéutico , Clorhidrato de Prasugrel , Estudios Prospectivos , Factores de Riesgo , Ticagrelor , Ticlopidina/análogos & derivados , Ticlopidina/uso terapéutico , Resultado del Tratamiento
4.
Horm Metab Res ; 41(10): 730-5, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19579180

RESUMEN

The biguanide derivative metformin is a potent anti-diabetic drug widely used in the treatment of type 2 diabetes mellitus. Its major effect on glucose metabolism consists in the inhibition of hepatic glucose production. Since the mechanisms of metformin action are only partially understood at the molecular level, we studied the regulation of the gene promoter activity of glucose-6-phosphatase (G6Pase), the central hepatic gluconeogenic enzyme, by this drug. We have found that both metformin and insulin inhibit the basal and dexamethasone/cAMP-stimulated G6Pase promoter activity in hepatoma cells. Since one of the pharmacological targets of metformin is AMP-activated protein kinase (AMPK) and activation of AMPK is known to inhibit hepatic glucose production by the suppression of G6Pase gene transcription, we studied the effect of AMPK in this context. Under nonstimulated conditions, the inhibitory effect of both insulin and metformin was partially counteracted to a similar extent by treatment with compound C, a specific inhibitor of AMPK. In contrast, under conditions of stimulation with dexamethasone and cAMP, treatment with compound C reversed the inhibitory effect of metformin on G6Pase promoter activity to a similar extent as compared to nonstimulated conditions, whereas the effect of insulin was almost resistant to treatment with the AMPK-antagonist. These data indicate a differential AMPK-dependent regulation of G6Pase gene expression by insulin and metformin under basal and dexamethasone/cAMP-stimulated conditions.


Asunto(s)
Diabetes Mellitus Tipo 2/metabolismo , Regulación Enzimológica de la Expresión Génica/fisiología , Glucosa-6-Fosfatasa/metabolismo , Hipoglucemiantes/farmacología , Insulina/farmacología , Metformina/farmacología , Quinasas de la Proteína-Quinasa Activada por el AMP , Animales , Línea Celular Tumoral , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/enzimología , Relación Dosis-Respuesta a Droga , Glucosa-6-Fosfatasa/genética , Fosforilación/fisiología , Regiones Promotoras Genéticas/fisiología , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Quinasas/metabolismo , ARN/química , ARN/genética , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
5.
IEEE Trans Neural Netw ; 19(2): 299-307, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18269960

RESUMEN

In this paper, we present a recursive algorithm for extracting classification rules from feedforward neural networks (NNs) that have been trained on data sets having both discrete and continuous attributes. The novelty of this algorithm lies in the conditions of the extracted rules: the rule conditions involving discrete attributes are disjoint from those involving continuous attributes. The algorithm starts by first generating rules with discrete attributes only to explain the classification process of the NN. If the accuracy of a rule with only discrete attributes is not satisfactory, the algorithm refines this rule by recursively generating more rules with discrete attributes not already present in the rule condition, or by generating a hyperplane involving only the continuous attributes. We show that for three real-life credit scoring data sets, the algorithm generates rules that are not only more accurate but also more comprehensible than those generated by other NN rule extraction methods.


Asunto(s)
Algoritmos , Interpretación Estadística de Datos , Redes Neurales de la Computación , Retroalimentación
6.
Offentl Gesundheitswes ; 52(12): 691-5, 1990 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-2149443

RESUMEN

The number of persons suffering from chronic mental disease but living outside the psychiatric hospital in the community, is rising, resulting in an increasing demand for facilities for occupation, occupational therapy and rehabilitation and for paid employment. The past few years have seen a distinct increase in the number of sheltered workplaces for the mentally ill. This development has also led to qualitative differentiation in the offers. In the region of Westphalia there are currently some 940 work places in special departments for the mentally handicapped at workshops for the disabled. Self-help enterprises and those offering opportunities for persons living on social benefits or pensions to supplement their income currently offer some 470 workplaces for the mentally ill, ten psychiatric hospitals are giving their former patients an opportunity to take part in occupational therapy as outpatients. Considerable differences are to be registered with regard to the offers of work, the forms of organization, the tasks involved and the types of supervision. Finally, a specialized psychosocial service has been established within the past four years by the head welfare office of the Landschaftsverband Westfalen-Lippe; this service is designed for the care of the mentally ill at their work place. Like many developments in social psychiatry, the differentiation of occupational rehabilitation has resulted from practical experience. Empirical findings on the indication for and efficiency of individual measures are virtually non-existent. A prospective five-year study is planned to investigate further results.


Asunto(s)
Trastornos Mentales/rehabilitación , Rehabilitación Vocacional , Talleres Protegidos/provisión & distribución , Servicios Comunitarios de Salud Mental/organización & administración , Empleo , Alemania , Humanos , Discapacidad Intelectual/rehabilitación , Asistencia Social en Psiquiatría
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA